The N.J. biotech has grown on strong demand for its pharmaceutical ingredients. It has been expanding facilities in the U.S., Italy, and Sweden.
Looking for leads, investment insights, or competitive intelligence?
Revenue and net income for the four quarters ended on or before April 30, 2017. Total return for the period ended June 30, 2017.